CA2099497A1 - Peptides possedant une activite anticoagulante - Google Patents

Peptides possedant une activite anticoagulante

Info

Publication number
CA2099497A1
CA2099497A1 CA002099497A CA2099497A CA2099497A1 CA 2099497 A1 CA2099497 A1 CA 2099497A1 CA 002099497 A CA002099497 A CA 002099497A CA 2099497 A CA2099497 A CA 2099497A CA 2099497 A1 CA2099497 A1 CA 2099497A1
Authority
CA
Canada
Prior art keywords
peptides
anticoagulant activity
scription
formula
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002099497A
Other languages
English (en)
Other versions
CA2099497C (fr
Inventor
Bernhard Schmied
Hans W. Hoeffken
Wilfried Hornberger
Harald Bernard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott GmbH and Co KG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2099497A1 publication Critical patent/CA2099497A1/fr
Application granted granted Critical
Publication of CA2099497C publication Critical patent/CA2099497C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CA002099497A 1991-02-07 1991-11-21 Peptides possedant une activite anticoagulante Expired - Fee Related CA2099497C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4103649A DE4103649A1 (de) 1991-02-07 1991-02-07 Neue antikoagulatorisch wirksame peptide
DEP4103649.2 1991-02-07
PCT/EP1991/002191 WO1992013879A1 (fr) 1991-02-07 1991-11-21 Nouveaux peptides a activite anticoagulante

Publications (2)

Publication Number Publication Date
CA2099497A1 true CA2099497A1 (fr) 1992-08-08
CA2099497C CA2099497C (fr) 2001-12-25

Family

ID=6424532

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002099497A Expired - Fee Related CA2099497C (fr) 1991-02-07 1991-11-21 Peptides possedant une activite anticoagulante

Country Status (10)

Country Link
US (1) US5393873A (fr)
EP (1) EP0570375B1 (fr)
JP (1) JP3315690B2 (fr)
AT (1) ATE121422T1 (fr)
CA (1) CA2099497C (fr)
DE (2) DE4103649A1 (fr)
DK (1) DK0570375T3 (fr)
ES (1) ES2071343T3 (fr)
MX (1) MX9203516A (fr)
WO (1) WO1992013879A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002219236B2 (en) * 2001-01-12 2006-02-09 Biogen International Gmbh Fumaric acid amides
WO2003022873A1 (fr) 2001-09-10 2003-03-20 Novel Science International Gmbh Composes organiques a activite biologique utilises comme inhibiteurs de thrombine et leur utilisation
CN101094867B (zh) 2004-10-19 2011-08-24 隆萨股份公司 用于固相肽合成的方法
CN101033249B (zh) * 2006-03-10 2011-05-11 周逸明 固相多肽合成比筏芦定的制备方法
US8685462B1 (en) 2012-09-17 2014-04-01 Biopep Solutions, Inc. Whole, leech saliva product and applications thereof
CN103408459B (zh) * 2013-08-21 2014-10-08 中国药科大学 4-氰基苯丙氨酸的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341032C (fr) * 1987-01-23 2000-06-20 John L. Krstenansky Peptides anti-coagulants
ZA883444B (fr) * 1987-05-21 1988-11-16
WO1990003391A1 (fr) * 1988-09-29 1990-04-05 Biogen, Inc. Peptides d'hirudine
WO1990006128A1 (fr) * 1988-12-05 1990-06-14 Biogen, Inc. Methodes et compositions pour inhiber l'agregation des plaquettes
AU630132B2 (en) * 1988-12-07 1992-10-22 Merrell Dow Pharmaceuticals Inc. Anticoagulant peptides
WO1991001328A1 (fr) * 1989-07-20 1991-02-07 Biogen, Inc. Derives de peptides d'hirudine
CA2035917C (fr) * 1990-02-13 2001-10-02 John L. Krstenansky Derives sulfonate, sulfate, phosphonate et phosphate stabilises de hirudine
DE4005591A1 (de) * 1990-02-22 1991-09-05 Behringwerke Ag Die blutgerinnung inhibierende peptide, verfahren zu ihrer herstellung und ihre verwendung

Also Published As

Publication number Publication date
ATE121422T1 (de) 1995-05-15
DK0570375T3 (da) 1995-07-03
US5393873A (en) 1995-02-28
ES2071343T3 (es) 1995-06-16
EP0570375B1 (fr) 1995-04-19
JP3315690B2 (ja) 2002-08-19
JPH06504989A (ja) 1994-06-09
EP0570375A1 (fr) 1993-11-24
CA2099497C (fr) 2001-12-25
WO1992013879A1 (fr) 1992-08-20
DE4103649A1 (de) 1992-08-13
MX9203516A (es) 1992-08-31
DE59105281D1 (de) 1995-05-24

Similar Documents

Publication Publication Date Title
CA2123051A1 (fr) Derives d'acides nor-biliaires, methodes pour les preparer et utilisation de ces composes a titre de medicaments
CA2201785A1 (fr) Nouveaux derives d'acide carboxylique, leur preparation et leur utilisation
BG104056A (en) Triazole compounds and their use as dopamine-d3-ligands
CA2105304A1 (fr) Inhibiteurs de l'elastase de neutrophile humaine et de la cathepsin g humaine
CA2262566A1 (fr) Derives de benzamidine et leur utilisation comme medicaments ayant un effet antagoniste vis-a-vis de ltb4
HUT63374A (en) Process for producing new benzoic acid derivatives having cardiovascular activity and pharmaceutical compositions comprising such active ingredient
CA2114313A1 (fr) Peptides bpc, leur preparation et utilisation
CA2082923A1 (fr) Composes de type sulfonyle
HUT44908A (en) Fungicides comprising triazolyl- or imidazolyl-group-substituted 2,5-dihydrofuran derivatives as active ingredient and process for producing the active ingredient and intermediaries thereof
MY128260A (en) Cyclopentane-and-pentene-b-amino acids
CA2071907A1 (fr) Proteines bcrf1 utilisees comme inhibiteurs de l'interferon-a
CA2094275A1 (fr) Methodes et compositions pour le traitement de maladies cytoproliferatives
CA2189527A1 (fr) Nouveaux inhibitieurs d'elastase
NO883582D0 (no) Katodisk elektrodeponerbart belegningspreparat.
IL99495A0 (en) Fungicidally active compounds,their production and their use as fungicides
AU591892B2 (en) Peptides
CA2263846A1 (fr) Nouveaux derives de pyranoside
IT8722167A0 (it) Struttura di valvola cardiaca artificiale ad elevato rendimento.
ES2128313T3 (es) Naftalimidas n-substituidas, su obtencion y empleo.
EP0390181A3 (fr) Dérivés de pérylène quinones (UCN-1028D)
EP0492478A3 (en) Tert-butyloxycarbonyl-l-tyrosyl-peptidoglycan monomer and 125 i-labelled derivative thereof, their preparation and use
DE3878988D1 (de) 1,2-di(4-isobutylphenyl)aethylen, dessen herstellung und verwendung als zwischenprodukt.
RU93049257A (ru) Изобутилзамещенные метансульфонил-хинолилметоксифенилциклоалкилуксусной кислоты
WO1990010006A3 (fr) NOUVEAUX β-METHOXYACRYLATES, LEUR PRODUCTION ET LEUR UTILISATION
DE59003728D1 (de) 4-Aryl-2-halogenimidazol-5-carbonsäureester, ihre Herstellung und Verwendung.

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed